Plasma Progastrin-releasing peptide (ProGRP) level well predicts the degree and duration of PSA response in patients with metastatic castration-resistant prostate cancer underwent enzalutamide

• M. Yashi,
• M. Yokoyama,
• H. Fuchizawa,
• N. Okubo,
• R. Kurashina,
• K. Takei,
• I. Suzuki,
• K. Sakamoto,
• A. Nukui,
• Y. Fukabori,
• T. Kamai

Affiliations

M. Yashi

M. Yokoyama

H. Fuchizawa

N. Okubo

R. Kurashina

K. Takei

I. Suzuki

K. Sakamoto

A. Nukui

Y. Fukabori

T. Kamai